Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics

Edwards Lifesciences (EW) reported $1.53 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 6.1%. EPS of $0.67 for the same period compares to $0.70 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.49 billion, representing a surprise of +2.85%. The company delivered an EPS surprise of +8.06%, with the consensus EPS estimate being $0.62.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- an ...